1. Home
  2. IH vs FATE Comparison

IH vs FATE Comparison

Compare IH & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iHuman Inc.

IH

iHuman Inc.

HOLD

Current Price

$1.84

Market Cap

116.0M

Sector

Real Estate

ML Signal

HOLD

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

HOLD

Current Price

$1.23

Market Cap

124.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IH
FATE
Founded
1996
2007
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
116.0M
124.6M
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
IH
FATE
Price
$1.84
$1.23
Analyst Decision
Buy
Analyst Count
0
7
Target Price
N/A
$3.92
AVG Volume (30 Days)
14.4K
1.8M
Earning Date
12-29-2025
03-04-2026
Dividend Yield
4.62%
N/A
EPS Growth
N/A
N/A
EPS
0.27
N/A
Revenue
$119,261,855.00
$7,137,000.00
Revenue This Year
$39.02
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.72
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.60
$0.66
52 Week High
$3.60
$1.94

Technical Indicators

Market Signals
Indicator
IH
FATE
Relative Strength Index (RSI) 29.09 60.08
Support Level $1.80 $1.02
Resistance Level $1.95 $1.32
Average True Range (ATR) 0.07 0.08
MACD 0.01 0.02
Stochastic Oscillator 10.80 71.30

Price Performance

Historical Comparison
IH
FATE

About IH iHuman Inc.

iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: